MLTX icon

MoonLake Immunotherapeutics

83 hedge funds and large institutions have $2.86B invested in MoonLake Immunotherapeutics in 2023 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 25 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
+40
Holders Change %
+93.02%
% of All Funds
1.31%
Holding in Top 10
10
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+400%
% of All Funds
0.16%
New
47
Increased
25
Reduced
8
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
VEA
76
Virtus ETF Advisers
New York
$207K +$207K +4,053 New
DWA
77
Dorsey Wright & Associates
California
$56.7K +$5.66K +111 +11%
TRCT
78
Tower Research Capital (TRC)
New York
$46.5K +$46.5K +912 New
Osaic Holdings
79
Osaic Holdings
Arizona
$41K +$37.1K +727 +957%
Citigroup
80
Citigroup
New York
$30.8K -$3.91M -76,673 -99%
New York State Common Retirement Fund
81
New York State Common Retirement Fund
New York
$8K +$8K +165 New
PTC
82
Private Trust Company
Ohio
$1.73K +$1.73K +34 New
Allianz Asset Management
83
Allianz Asset Management
Germany
$224 +$224 +4,400 New
GPP
84
Great Point Partners
Connecticut
-$5.95M -278,334 Closed
CSS
85
Cubist Systematic Strategies
Connecticut
-$1.28M -59,858 Closed
Point72 Asset Management
86
Point72 Asset Management
Connecticut
-$636K -29,748 Closed
Jane Street
87
Jane Street
New York
-$557K -26,034 Closed
BHCM
88
Boulder Hill Capital Management
New York
-$310K -14,500 Closed
Ensign Peak Advisors
89
Ensign Peak Advisors
Utah
-$248K -11,575 Closed
UBS Group
90
UBS Group
Switzerland
-$170K -7,960 Closed